Cancer media resource company CURE Media Group stated on Monday that Lung Cancer Alliance is now part of the former's Strategic Alliance Partnership (SAP) Programme to empower the lung cancer community through educational efforts.
The SAP Programme is designed to facilitate an open exchange of information among trusted peers, with focus in improving care in the lung cancer community.
Under the terms of the partnership, Lung Cancer Alliance will share valuable content through CURE magazine, readers will have access to unprecedented resources including the latest research, interviews and articles, as well as help patients with cancer and their caregivers make better informed decisions.
Established in 1995, Lung Cancer Alliance is a leading non-profit health organisations committed to serving the lung cancer community. It empowers a caring community by helping people navigate the paths of early detection, diagnosis, treatment and long-term survival. It leverages insights into the lung cancer community to improve care, amplify awareness, drive advocacy and lead transformative research, with the vision of tripling survivors in the next decade.
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
D3 Bio announces Series A+ Round completion to advance innovative oncology pipeline
Dizal's sunvozertinib receives US FDA Breakthrough Therapy Designation
Merck launches Phase 3 trial of MK-1084 and KEYTRUDA combination in metastatic NSCLC
Trevi Therapeutics names new vice president of Clinical Development
Personalis validates NeXT Personal test for ultra-sensitive MRD detection
Merck reports lung cancer trial failed to meet endpoints
BerGenBio ASA starts Phase 2a portion of BGBC016 clinical study of bemcentinib